COVID-19 en Latinoamérica: una revisión sistemática de la literatura y análisis bibliométrico
2020; National University of Córdoba; Volume: 22; Issue: 2 Linguagem: Inglês
10.15446/rsap.v22n2.86878
ISSN2539-3596
AutoresDavid A. Forero‐Peña, Fhabián S. Carrión‐Nessi, Natasha A. Camejo‐Ávila, Magda Julieth Forero-Peña,
Tópico(s)COVID-19 Clinical Research Studies
ResumoDescribe and analyze scientific activity on COVID-19 in Latin America.Through a systematic review of the literature in PubMed, LILACS, and the preprinted repositories BioRxiv and medRxiv, all available documents on COVID-19 in Latin America from January 1 to April 24, 2020, were retrieved for review and bibliometric analysis.A total of 29 publications were included in the analysis. The country with the most scientific production was Brazil (10/29; 34,4%) followed by Colombia (6/29; 20,6%) and Mexico (6/29; 20,6%). The university with the most articles was the Technological University of Pereira, Colombia (5/29; 17,2%). 41,3% of the publications were preprinted documents. Most of the excluded studies were editorial comments or expert opinions. Three out of four investigations had an epidemiological focus (21/29; 72,4%); Limited studies on diagnosis (5/29; 17,24%), pathophysiology (2/29, 2,8%) and therapeutic.Despite the exponential growth of publications in the world, there is a limited amount of information on the behavior of this infection in Latin America. The publication of studies with high methodological quality is required, which provide knowledge of the impact of the pandemic in the region.
Referência(s)